You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2024

OSTEOLITE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Osteolite patents expire, and when can generic versions of Osteolite launch?

Osteolite is a drug marketed by Pharmalucence and is included in one NDA.

The generic ingredient in OSTEOLITE is technetium tc-99m medronate kit. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m medronate kit profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Osteolite

A generic version of OSTEOLITE was approved as technetium tc-99m medronate kit by CARDINAL HEALTH 414 on December 31st, 1969.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for OSTEOLITE?
  • What are the global sales for OSTEOLITE?
  • What is Average Wholesale Price for OSTEOLITE?
Summary for OSTEOLITE
US Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
DailyMed Link:OSTEOLITE at DailyMed
Drug patent expirations by year for OSTEOLITE

US Patents and Regulatory Information for OSTEOLITE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmalucence OSTEOLITE technetium tc-99m medronate kit INJECTABLE;INJECTION 017972-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.